JAMA Otolaryngology–Head & Neck Surgery —The Year in Review, 2025 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Annual Review of JAMA Otolaryngology–Head & Neck Surgery: Highlights from 2025

  • By

  • Jay F. Piccirillo

  • May 1, 2026

Share

Objective:

Expand to include the significance of the findings.

Key Findings:
  • Include more detail on significance, especially for AI and thyroid disease.
Interpretation:

Specify how advancements impact clinical practice.

Limitations:
  • Expand to include the need for comprehensive studies.
Conclusion:

Reiterate the importance of ongoing research.

Original Source(s)

JAMA Otolaryngology–Head & Neck Surgery —The Year in Review, 2025

  • by Jay F. Piccirillo

  • May 1, 2026

Related Content

Cochleovestibulopathy as a Paraneoplastic Syndrome Linked to Breast Cancer: A Case Study of Two Patients and Review of Existing Literature

Type 2 Diabetes Linked to SSNHL Risk

Mendelian randomization analysis shows independent association, with no link for type 1 diabetes, obesity, or hyperlipidemia.

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.